deltatrials
Completed PHASE4 INTERVENTIONAL 3-arm NCT00979628

Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) (Basal-Plus)

Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus

Sponsor: Guillermo Umpierrez, MD

Conditions Hyperglycemia Type 2 Diabetes
Interventions Basal Bolus Basal Plus sliding scale regular insulin (SSRI)
Updated 9 times since 2017 Last updated: Sep 14, 2018 Started: Jan 31, 2010 Primary completion: Mar 31, 2012 Completion: Jun 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00979628, this PHASE4 trial focuses on Hyperglycemia and Type 2 Diabetes and remains completed. Sponsored by Guillermo Umpierrez, MD, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotCompleted~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Nov 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jun 2018 — Nov 2018 [monthly]

    Completed PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Guillermo Umpierrez, MD
  • Medical University of South Carolina
  • Sanofi
  • Texas A&M University
Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations